Who Is a Danger to Others: The “Mentally Ill” or the Powerful?
If the cultural and socioeconomic structures of society had, from the beginning, allowed me to function, and even thrive, I undoubtedly never would have felt a need for antidepressants and “therapy.”
A Story of Forced Hospitalization From a Legal Perspective
If I had any legal rights, I knew nothing about them. And the hospital cared even less about them. As a law student, I would like to share the legal rights I did have in the state of California and how they were violated from the very start.
Research Explores the Experience of Benzodiazepine Withdrawal
A new study reveals many benzodiazepine users are misinformed about the risks of withdrawal and experience devastating consequences.
The Year Of Potentiality
I lost three years of my life to my first psychosis. I am living proof that your entire world can be smashed into a trillion pieces and you can recover and turn the broken pieces of glass into a kaleidoscope.
What Helped—and What Didn’t Help—My Recovery
In order to recover, it was necessary to give up the psychiatric treatment system, and the idea that I need something from that system, that I belong there.
August 20, 1985: The Day My Psychotic Episodes Ended
I didn’t know that I had never fully experienced my emotional pain until I was thrown into an altered state. With “psychosis” I plowed through layers and layers of pain, alone in the night.
The New York Times Confidently Misinterprets a New ECT Study
The New York Times article paints a rosy picture of ECT, but it’s based on a misleading study and dismisses the plentiful research on ECT’s harms.
Envisioning Psychiatric Drug Freedom
Psychiatric meds can shut down the emotions and consciousness enough to make it possible to tolerate dynamics that would inspire rage or surges of empowered activity without the meds. It can be helpful to look closely at these blocks and start to create a map to freedom, understanding that it is a complex process that involves not only the physiology of the body of the individual taking meds, but the architecture of the social system around that person.
Not Going Quietly
A few years ago, I was asked to see a man called Chris Rushworth. He was referred to me for anger issues. Chris had a restlessness about him, frequently shifting his legs from side to side. He had been on antipsychotic medication for 25 years.
Debunking The Latest Gene Study
The researchers suggest that their finding implies a common genetic cause behind five different “disorders.” This is big news! If true, it validates the biomedical view of mental “illness” and suggests that future medical treatments could “cure” these conditions. However, that grand conclusion is not supported by the data.
Has Psychiatry Gone Uniquely Astray?
Science is supposed to be evidence-respecting and thereby open-minded; psychiatry is presently not. But is psychiatry really unique in this respect? Is it the only field of medicine where dogmatically held theories contrary to evidence have held sway for long periods?
How Do We Test the Effects of Long-Term Exposure to Antipsychotics?
A new attempt to study the neurological effects of long-term exposure to antipsychotics uses healthy volunteers on minimal doses for 15 days.
Integrating Indigenous Healing Practices and Psychotherapy for Global Mental Health
As the Global Mental Health Movement attempts to address cross-cultural mental health disparities, a new article encourages integrating traditional healing practices with psychotherapy.
Positive Antidepressant Study “Misleading” and “Erroneous”
An analysis of last year’s positive finding in The Lancet about antidepressant efficacy shows errors, obfuscations, and misrepresentations.
Disinhibited
The party would continue for a time, but an inevitable crash ensued. I left my family, was fired from my job for uncontrollably screaming at my boss, and gambled away whatever money I had left in the stock market. A debilitating depression soon began, of a magnitude I could not previously have imagined. I had lost everyone and everything in my life.
Valproate Linked to Decreased Brain Volume in Children Diagnosed with Bipolar Disorder
Researchers find that valproate decreases brain volume in a region associated with emotion processing across all participants.
Bob Fiddaman: Taking on the Pharmaceutical Regulators and the Seroxat Scandal
Today on the MIA podcast we talk to Bobby Fiddaman about his experiences of the mental health system, his research and campaigning over the years and his relationships with the UK and US pharmaceutical regulatory bodies.
Are Drug Side Effects Driving Depression Rates?
A new study finds that more than a third of Americans are taking prescription drugs that can cause depressive symptoms as a side-effect.
New CDC Data Underscores Need to Address Adverse Childhood Experiences
New prevention strategies are needed based on our increasing understanding of the impacts of Adverse Childhood Experiences (ACEs).
ADHD: Disempowerment By Diagnosis
Giving a diagnosis of ADHD can profoundly disempower students and lead to what psychologists call “learned helplessness.” Isn’t it time for those of us in education to reclaim our profession? Who are the teaching and learning experts? Doctors? Drug companies? We are! And if we don’t stand up—for our students—against disempowering diagnoses and harmful drugs, who will?
Challenging Resilience as a Buzzword: Toward a Contextualized Resilience Model
Researcher Dr. Silke Schwarz highlights how Western psychology’s construction of individual resilience deflects emphasized individual pathology and deflects efforts at structural change.
Living Together – With More Resilience and Less Medication
My own experiences have shown that specific exercises can help me to recognize the early symptoms of psychosis even earlier and more subtly, and reduce their intensity — even the delusions!
“Diagnostic Dissent”: Experiences of Individuals Who Disagreed With Their Diagnosis
Researchers investigate the first-person experiences of people who disagreed with their psychiatric diagnosis of psychosis.
Critical Psychiatry Textbook, Chapter 8: Depression and Mania (Affective Disorders) (Part Five)
Peter Gøtzsche continues the discussion of the pharmaceutical industry’s manipulation of depression pill trials for children and adolescents.
Inner Fire: Where Seekers Have a Choice
A Vermont residential community program helps people taper or stay off medications with holistic care embedded in a pastoral setting.